Literature DB >> 12626455

Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Raphael P Viscidi1, Dana E M Rollison, Emma Viscidi, Barbara Clayman, Elizabeth Rubalcaba, Richard Daniel, Eugene O Major, Keerti V Shah.   

Abstract

Enzyme immunoassays (EIAs) for detection of serum antibodies to simian virus 40 (SV40), BK virus (BKV), and JC virus (JCV) were developed by using virus-like-particles (VLPs) produced in insect cells from recombinant baculoviruses expressing the VP1 protein of the respective virus. Rhesus macaque sera with neutralizing antibodies to SV40 showed a high level of reactivity in the SV40 VLP-based EIA, and these sera also showed lower levels of reactivity in the BKV and JCV VLP-based EIAs. Rhesus macaque sera negative for neutralizing antibodies to SV40 were negative in all three EIAs. Competitive binding assays showed that SV40 VLPs inhibited BKV reactivity. In rhesus macaque sera, high optical density (OD) values for antibodies to SV40 VLPs were correlated with high OD values for antibodies to BKV but not with high OD values for antibodies to JCV VLPs. Human sera with neutralizing antibodies to SV40 were more reactive to SV40 VLPs than human sera without neutralizing antibodies to SV40. The greater SV40 reactivities of human sera were correlated with greater reactivities to BKV VLPs but not JCV VLPs. These data suggest that cross-reactivity with BKV antibodies may account for part of the low-level SV40 reactivity seen in human sera. With their greater versatility and their suitability for large-scale testing, the VLP-based EIAs for SV40, BKV, and JCV are likely to contribute to a better understanding of the biology of these viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626455      PMCID: PMC150538          DOI: 10.1128/cdli.10.2.278-285.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  33 in total

1.  Virology. Monkey virus link to cancer grows stronger.

Authors:  Dan Ferber
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

Review 2.  Human exposure to SV40: review and comment.

Authors:  K Shah; N Nathanson
Journal:  Am J Epidemiol       Date:  1976-01       Impact factor: 4.897

3.  Small-t and large-T antigens cooperate to drive cell proliferation.

Authors:  K Rundell; S Gaillard; A Porrás
Journal:  Dev Biol Stand       Date:  1998

4.  Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells.

Authors:  A Kosukegawa; F Arisaka; M Takayama; H Yajima; A Kaidow; H Handa
Journal:  Biochim Biophys Acta       Date:  1996-05-21

5.  Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.

Authors:  R S Hamilton; M Gravell; E O Major
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells.

Authors:  D Chang; C Y Fung; W C Ou; P C Chao; S Y Li; M Wang; Y L Huang; T Y Tzeng; R T Tsai
Journal:  J Gen Virol       Date:  1997-06       Impact factor: 3.891

7.  Papillomavirus-like particles induce acute activation of dendritic cells.

Authors:  P Lenz; P M Day; Y Y Pang; S A Frye; P N Jensen; D R Lowy; J T Schiller
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

8.  Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors:  M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

9.  Simian virus 40 and pleural mesothelioma in humans.

Authors:  H D Strickler; J J Goedert; M Fleming; W D Travis; A E Williams; C S Rabkin; R W Daniel; K V Shah
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-06       Impact factor: 4.254

10.  Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.

Authors:  Dana E M Rollison; Kathy J Helzlsouer; Anthony J Alberg; Sandra Hoffman; Jean Hou; Richard Daniel; Keerti V Shah; Eugene O Major
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

View more
  52 in total

1.  Inhibitory interactions between BK and JC virus among kidney transplant recipients.

Authors:  Xingxing S Cheng; Daniel L Bohl; Gregory A Storch; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Eugene O Major; Parmjeet Randhawa; Karen L Hardinger; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.

Authors:  Raphael P Viscidi; Dana E Rollison; Vernon K Sondak; Barbara Silver; Jane L Messina; Anna R Giuliano; William Fulp; Abidemi Ajidahun; Daniela Rivanera
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

3.  Homologous SV40 RNA trans-splicing: a new mechanism for diversification of viral sequences and phenotypes.

Authors:  Joachim Eul; Volker Patzel
Journal:  RNA Biol       Date:  2013-10-14       Impact factor: 4.652

4.  Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

Authors:  Ludmila Krymskaya; Madeva C Sharma; Joy Martinez; Wahajul Haq; Eric C Huang; Ajit P Limaye; Don J Diamond; Simon F Lacey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 5.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.

Authors:  Jing Lu Kroll; Craig Beam; Shaobing Li; Raphael Viscidi; Bonnie Dighero; Alice Cho; David Boulware; Mark Pescovitz; Adriana Weinberg
Journal:  J Clin Virol       Date:  2013-02-17       Impact factor: 3.168

7.  BK virus antibody titers and intensity of infections after renal transplantation.

Authors:  Daniel L Bohl; Daniel C Brennan; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Eugene O Major; Gregory A Storch
Journal:  J Clin Virol       Date:  2008-08-03       Impact factor: 3.168

8.  JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

Authors:  Nina Khanna; Marcel Wolbers; Nicolas J Mueller; Christian Garzoni; Renaud A Du Pasquier; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Raphael Viscidi; Manuel Battegay; Hans H Hirsch
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma.

Authors:  Joseph J Carter; Kelly G Paulson; Greg C Wipf; Danielle Miranda; Margaret M Madeleine; Lisa G Johnson; Bianca D Lemos; Sherry Lee; Ashley H Warcola; Jayasri G Iyer; Paul Nghiem; Denise A Galloway
Journal:  J Natl Cancer Inst       Date:  2009-09-23       Impact factor: 13.506

10.  Serologic evidence of frequent human infection with WU and KI polyomaviruses.

Authors:  Nang L Nguyen; Binh Minh Le; David Wang
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.